TXMD

Therapeuticsmd Inc

2.210

-0.030-1.34%

After Hours: 2.170 -0.040 -1.81%19:30 09/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.230/2.240

TODAY RANGE2.180-2.230

VOL8.81K

MARKET CAP25.58M

52 WEEK RANGE0.9900-2.950

AVG VOL (3M)38.46K

% TURNOVER0.07%

TURNOVER--

P/E (TTM)-116.9312

% RANGE2.23%

EPS(TTM)-0.0189

P/E(FORWARD)13.81

P/B0.9428

BVPS2.344

DIVIDEND--

P/S8.46

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP23.27M

SHARES OUTSTANDING11.57M

NEXT EARNINGS11/10-11/16

FREE FLOAT10.53M

LOT SIZE1

EX-DATE05/09/2022

News

Press Releases

Financial Reports

Profile

Dow Jones·5d ago
TherapeuticsMD Inc. Stock Climbs 4.1%, Outperforms Market
Dow Jones·08/25 20:32
TherapeuticsMD Inc. Stock Rallies 10.1%, Outperforms Market
TipRanks·08/11 20:41
TherapeuticsMD Q2 Results and Strategic Alternatives Review
Seeking Alpha·08/11 20:27
Therapeutics MD reports Q2 results
Dow Jones·08/11 20:00
Press Release: TherapeuticsMD Announces Second Quarter 2026 Financial Results
Dow Jones·07/06 20:32
TherapeuticsMD Inc. Stock Slides 6.6%, Underperforms Market
Dow Jones·06/29 20:34
TherapeuticsMD Inc. Stock Advances 6.2%, Outperforms Market
Dow Jones·06/18 20:32
TherapeuticsMD Inc. Stock Slides 14.1%, Underperforms Market
NASDAQ·06/15 02:02
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watch
Dow Jones·06/12 20:32
TherapeuticsMD Inc. Stock Advances 20.9%, Outperforms Market
Dow Jones·06/08 20:34
TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market
TipRanks·05/12 20:47
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
Seeking Alpha·05/12 20:24
Therapeutics MD reports Q1 results
Dow Jones·04/27 20:33
TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market
Dow Jones·04/06 20:32
TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market

Same Industry

Name/Symbol

Change%

Price

Therapeuticsmd Inc

TXMD

-1.34%

2.210

McKesson

MCK

-1.45%

907.99

Biogen Inc

BIIB

-1.64%

220.83

AMGN

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-6.69%

0.1380

Celgene

CELG

0.00%

108.24

Lilly Eli & Co

LLY

-0.88%

Johnson & Johnson

JNJ

-1.15%

275.23

Abbvie Inc

ABBV

-1.44%

256.46

Zoetis Inc

ZTS

-0.63%

75.81

GILD

Novo-Nordisk A/S

NVO

-1.92%

46.60

Bristol-Myers Squibb Co

BMY

-1.87%

66.82

ALXN

Pfizer

PFE

-1.25%

28.45

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.90%

159.99

RDY

GSK PLC

GSK

-1.93%

49.89

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.